SmartKem (SMTK) Financials

SmartKem’s Q2 2026 statements show a company with a stronger balance sheet but limited operating traction. The quarter included a sharp reduction in net loss and operating expenses, but revenue fell to zero and cash continued to decline. Much of the company’s recent financial support has come from equity financing rather than business operations.

• Net loss improved substantially. SmartKem reported a net loss of $3.3 million in Q2 2026, compared with a $19.4 million loss in Q1 2026. The Q2 loss was also lower than the $3.9 million loss in Q3 2025 and the $2.1 million loss in Q4 2025, although the improvement was partly influenced by large and unusual non-operating items.
• Operating expenses declined. Total operating expenses fell to $1.4 million in Q2 from $2.6 million in Q1 and $2.5 million in Q4 2025. Selling, general and administrative expense declined to $778,000, while research and development expense fell to $703,000.
• The balance sheet currently has positive equity and limited reported debt. At June 30, 2026, SmartKem reported $9.7 million of shareholders’ equity and only $675,000 of total liabilities. This represents a significant improvement from the negative equity reported in Q2 2025 and Q3 2025.
• Current assets exceed current liabilities by a wide margin. Current assets totaled $10.4 million, including $6.2 million of note and lease receivables, compared with $675,000 of current liabilities. This provides a more favorable short-term liquidity position than the company had during much of 2025.
• Financing activity provided $4.5 million of cash in Q2. SmartKem raised $5.6 million through common-equity issuance, partially offset by a $958,000 share repurchase and other financing outflows. The financing helped offset operating cash burn, but it also highlights the company’s dependence on capital markets.
• Cash usage remains elevated. Net cash from operating activities was negative $1.8 million in Q2, compared with negative $1.6 million in Q1 and negative $1.4 million in Q4 2025. The company also spent $7.4 million on investing activities in Q2, causing cash and equivalents to fall from $7.6 million at the end of Q1 to $3.7 million at the end of Q2.
• Revenue momentum deteriorated. SmartKem reported no revenue in Q2 2026, following just $20,000 in Q1. This compares with $561,000 in Q4 2025, $81,000 in Q3 2025 and $32,000 in Q2 2025. The company remains far from generating revenue sufficient to cover its operating costs.
• The company remains structurally unprofitable. SmartKem has reported recurring quarterly operating losses throughout the available period, with operating expenses consistently far above revenue. Retained earnings were negative $147.8 million at June 30, 2026, reflecting substantial accumulated losses.
• Shareholder dilution is a significant risk. Weighted-average basic shares outstanding increased to 23.5 million in Q2 2026 from 14.4 million in Q1 and 8.2 million in Q4 2025. Additional equity financing may be necessary if operating cash flow does not improve, potentially reducing existing shareholders’ ownership percentage.
• Q2 earnings quality was difficult to assess. The income statement included $43.3 million of interest and investment income and a $45.2 million other expense, producing a net other expense of $1.9 million. These unusually large items, along with $2.4 million of non-cash cash-flow adjustments, make the reported net loss less representative of underlying operating performance.

Overall, SmartKem’s liquidity and equity position improved markedly after recent financing, and management reduced quarterly operating expenses. However, zero revenue, persistent operating cash burn, heavy reliance on equity issuance and substantial accumulated losses remain the central risks for investors. The company’s financial outlook will depend largely on whether it can convert its technology and research efforts into consistent commercial revenue before available cash is depleted.